Results 121 to 130 of about 46,034 (246)
What anabolic–androgenic steroids reveal about the limits of current harm reduction models
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski +2 more
wiley +1 more source
The cerebral palsy directed acyclic graph: A structural causal model of aetiology
The first international cerebral palsy directed acyclic graph (CP‐DAG) maps over 100 nodes and 370 links across biological, clinical, and social domains, offering a unified causal framework to guide research and identify knowledge gaps. This original article is commented by Gagliardi on pages 1497–1498 of this issue.
Shona Goldsmith +9 more
wiley +1 more source
Polycythemia at Moderate Altitude: Rethinking Screening for Polycythemia Vera
BACKGROUND: Polycythemia is a clinical condition characterized by increased red blood cell mass (RCM). With the aim to increase the sensitivity of capturing patients with polycythemia vera (PV), the hemoglobin (Hb) and hematocrit (Hct) thresholds were ...
Husain Y. Alkhaldy, Ali M. Assiri
doaj +1 more source
Polycythemia in Nephrotic Syndrome
The association of polycythemia with kidney diseases such as adult polycystic kidney disease, kidney tumors, and renal artery stenosis is well known. However, polycythemia associated with nephrotic syndrome (NS) is rarely seen and documented.
Anagha Auradkar +2 more
doaj +1 more source
A Case Report: Cushing's Disease Presenting with Polycythemia and Venous Thromboembolism
We present the case of a woman with Cushing’s disease who had originally received a diagnosis of primary polycythemia. Her major complaints were headache, weakness, and blushing of the face.
İnan Anaforoğlu +3 more
doaj
Endodontic Care for Patients with Polycythemia: Clinical Considerations and Case Analysis
Polycythemia is a myeloproliferative neoplasm characterized by uncontrolled proliferation of red blood cells due to mutations in early hematopoietic cells, often linked to Janus kinase 2 (JAK2) gene mutations.
Dian Lestari Putri Nugroho +3 more
doaj +1 more source
Nine treatments of 1000 mL therapeutic phlebotomy in a subject with polycythemia: A case report
Large‐volume therapeutic phlebotomy is the mainstay of hemochromatosis treatment and offers an opportunity to investigate the hemodynamic changes during acute hypovolemia. An otherwise healthy 64‐year‐old male with hemochromatosis participated.
William J. Morton +5 more
doaj +1 more source
Cerebral abscess is a rare but potentially fatal complication of cyanotic congenital heart disease, in which chronic hypoxia, polycythaemia and right-to-left shunting allow bacteraemia to bypass pulmonary filtration.
Fanny Puspita Haryono +2 more
doaj

